Article

Bone Health Takes a Hit After Bariatric Surgery

Weight loss surgery can reduce bone mass and strength and increase the risk of fractures.

Image credit: ©design36/Shutterstock.com

Bariatric surgery can cause declines in bone mass and strength, and it is linked with an increased risk of bone fractures, according to a recent review published in JBMR Plus. Skeletal changes after surgery appear early and continue even after weight loss plateaus and weight stabilizes. Nutritional factors, mechanical unloading, hormonal factors, and changes in body composition and bone marrow fat may contribute to poor bone health.

Most studies have examined the effects of the Roux-en-Y gastric bypass procedure, which was the most commonly performed weight loss procedure worldwide until it was very recently overtaken by sleeve gastrectomy. Because sleeve gastrectomy is a newer procedure, its skeletal effects have not yet been well defined.

The review’s findings indicate that clinical guidelines on weight loss surgery should address bone health as a priority. “Current clinical guidelines do address bone health, but most recommendations are based on low-quality evidence or expert opinion,” said co-author Dr. Anne Schafer, of the University of California, San Francisco and the San Francisco VA Health Care System. "Future studies should address strategies to avoid long-term skeletal consequences of these otherwise beneficial procedures.”

References:

Gagnon C, Schafer AL. Bone health after bariatric surgery. JBMR Plus. 30 March 2018. https://doi.org/10.1002/jbm4.10048.

Weight loss surgery may cause significant skeletal health problems [press release]. Hoboken, NJ: John Wiley & Sons, Inc.; May 2, 2018.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.